ANTITUMOR AGENTS CONTAINING RNA, METHODS FOR ACTIVATING IMMUNE CELLS, METHODS FOR SUPPRESSING METASTASIS OF TUMOR CELLS, IMMUNOSTIMULANTS, ENHANCERS OF ANTITUMOR EFFECTS OF ANTITUMOR AGENTS AND PHARMACEUTICAL COMPOSITIONS

Title:

Document Type and Number:

Japanese Patent JP2021195364

Kind Code:

A

Abstract:

To provide an antitumor agent containing RNA as the effective ingredient that activates immune cells.SOLUTION: Disclosed is an antitumor agent containing at least one RNA selected from the group consisting of following (i), (ii) and (iii); where (i) an RNA comprising a base sequence of SEQ ID NO:3 or SEQ ID NO:6; (ii) an RNA comprising a base sequence having 90% or more identity to the base sequence of SEQ ID NO:3 or SEQ ID NO:6 and capable of increasing the antitumor activity of cells; and (iii) an RNA having part of the base sequence of (i) or (ii) and capable of increasing the antitumor activity of cells.SELECTED DRAWING: Figure 7

More Like This:

WO/2012/127739	NOVEL CARRIER MOLECULE AND METHOD BOTH FOR DELIVERING RNA INTO CYTOPLASM USING NEAR-INFRARED LIGHT
WO/2023/152398	PREPARATION FOR USE IN A METHOD FOR THE TREATMENT AND/OR PREVENTION OF A DISEASE
JP2020524996	Methods and Compositions for Tumor Cytotoxic Activation via Human Gamma Delta T Cells

Inventors:

HIRATSUKA SACHIE
TOMITA TAKESHI

Application Number:

JP2021013457A

Publication Date:

December 27, 2021

Filing Date:

January 29, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV SHINSHU

International Classes:

A61K31/7105; A61P35/00; A61P35/04; A61P37/04; A61P43/00; C12N5/078; C12N15/117; C12N15/25

Attorney, Agent or Firm:

Patent Business Corporation Saegusa International Patent Office

Previous Patent: Cleaning composition

Next Patent: Compounds, liquid crystal compositions and liquid crystal display devices